ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.3272
0.00%
Brent Oil
73.44
0.00%
Bitcoin
95,010.00
-0.14%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Virbac SA (VIRP) Cotización

Virbac SA

Virbac SA (VIRP)

EU
316.50
6.50
(2.10%)
Cerrado 29 Diciembre 10:30AM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
316.50
Postura de Compra
311.50
Postura de Venta
318.00
Volume Operado de la Acción
2,847
309.50 Rango del Día 318.00
306.00 Rango de 52 semanas 400.00
Capitalización de Mercado [m]
2.672B
Precio Anterior
310.00
Precio de Apertura
310.50
Hora
8
@
316.5
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
4,014
Acciones en circulación
8,443,062
Rendimiento del Dividendo
0.42%
Ratio Precio/Utilidad
22.03
Beneficio por acción (BPA)
14.37
turnover
1.26B
Beneficio neto
121.3M

Acerca de Virbac SA

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.virbac.com
Sede
Carros, Fra
Fundado
1968
Virbac SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker VIRP. The last closing price for Virbac was 310.00 €. Over the last year, Virbac shares have traded in a share price range of 306.00 € to 400.00 €.

Virbac currently has 8,443,062 shares in issue. The market capitalisation of Virbac is 2.62 € billion. Virbac has a price to earnings ratio (PE ratio) of 22.03.

VIRP Últimas noticias

Más noticias

Virbac : Declaration of the number of shares and voting rights 11/2024

Virbac : Declaration of the number of shares and voting rights 11/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares...

06 Diciembre 2024
UK Regulatory

Virbac : Déclaration d'actions et de droits de vote 11/2024

Virbac : Déclaration d'actions et de droits de vote 11/2024 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions...

06 Diciembre 2024
UK Regulatory

Virbac: Türkiye: Virbac acquires its companion animal distributor

Virbac: Türkiye: Virbac acquires its companion animal distributor On December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion...

03 Diciembre 2024
UK Regulatory

VIRBAC: Turquie : Virbac acquiert son distributeur de produits pour animaux de compagnie

VIRBAC: Turquie : Virbac acquiert son distributeur de produits pour animaux de compagnie     Le 2 décembre, nous avons finalisé l'acquisition de la société turque Mopsan, spécialisée dans la...

03 Diciembre 2024
UK Regulatory

Virbac : Déclaration d'actions et de droits de vote 10/2024

Virbac : Déclaration d'actions et de droits de vote 10/2024 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions...

06 Noviembre 2024
UK Regulatory

Virbac : Declaration of the number of shares and voting rights 10/2024

Virbac : Declaration of the number of shares and voting rights 10/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares...

06 Noviembre 2024
UK Regulatory

Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.

Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained. KEY FIGURES Revenue at the end of September   €1 042.1M...

17 Octubre 2024
UK Regulatory

VIRBAC: Croissance soutenue du chiffre d’affaires à fin septembre de +12,6% et +8,6% à taux de change et périmètre constants. Maintien des objectifs pour 2024.

VIRBAC: Croissance soutenue du chiffre d’affaires à fin septembre de +12,6% et +8,6% à taux de change et périmètre constants. Maintien des objectifs pour 2024. CHIFFRES CLÉS Chiffre d’affaires à...

17 Octubre 2024
UK Regulatory

Virbac : Déclaration d'actions et de droits de vote 09/2024

Virbac : Déclaration d'actions et de droits de vote 09/2024 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions...

03 Octubre 2024
UK Regulatory

Virbac : Declaration of the number of shares and voting rights 09/2024

Virbac : Declaration of the number of shares and voting rights 09/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares...

03 Octubre 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
161.93236714976310.53183062362309.96091435DE
4-5-1.55520995334321.53303062856317.8686739DE
12-51.5-13.99456521743684003064014344.21187719DE
26-18-5.38116591928334.54003063540352.25421883DE
52-34-9.70042796006350.54003063805349.71343442DE
156-98.5-23.7349397594154422155041314.83130936DE
2607531.0559006211241.5448.5132.25722283.19828765DE

VIRP - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Virbac?
El precio actual de las acciones de Virbac es 316.50 €
¿Cuántas acciones de Virbac están en circulación?
Virbac tiene 8,443,062 acciones en circulación
¿Cuál es la capitalización de mercado de Virbac?
La capitalización de mercado de Virbac es EUR 2.62B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Virbac?
Virbac ha negociado en un rango de 306.00 € a 400.00 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Virbac?
El ratio precio/beneficio de Virbac es 22.03
¿Cuál es el ratio de efectivo a ventas de Virbac?
El ratio de efectivo a ventas de Virbac es 2.11
¿Cuál es la moneda de reporte de Virbac?
Virbac presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Virbac?
El último ingresos anual de Virbac es EUR 1.26B
¿Cuál es el último beneficio anual de Virbac?
El último beneficio anual de Virbac es EUR 121.3M
¿Cuál es la dirección registrada de Virbac?
La dirección registrada de Virbac es 1ERE AVENUE 2065 M LID, CARROS, 06516
¿Cuál es la dirección del sitio web de Virbac?
La dirección del sitio web de Virbac es www.virbac.com
¿En qué sector industrial opera Virbac?
Virbac opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
15.95 €
(2,146.48%)
2.17k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.87 €
(40.22%)
2.43M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
110.23k
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
ALEUPEuroplasma
0.0413 €
(-14.67%)
3.93M
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ATOAtos SE
0.0027 €
(17.39%)
3.02B
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
NEOENNeoen SA
39.83 €
(0.73%)
81.42M
BCPBanco Comercial Portugues SA
0.4602 €
(2.04%)
75.06M
ALHPIHopium SA
0.005 €
(0.00%)
19.56M

Discusión

Ver feed completo
flipper44 flipper44 3 minutos hace
Ex has always said, for years, 99% chance it will not be approved. His goal since he got here is to convince people it won’t. One of his backups, investor082 covers a different angle. He states there will be approval but no financing.
NWBO
GrantHorvat1 GrantHorvat1 6 minutos hace
"Chart is a disaster"

Tells me all I need to know ffs lol...

Not that I didn't know it already about you...

Youre a WEIRDO...

GVSI
SkeBallLarry SkeBallLarry 16 minutos hace
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
SkeBallLarry SkeBallLarry 16 minutos hace
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
Phoenix2020 Phoenix2020 17 minutos hace
Friday's daily short sale volume was 74.61% (as reported by FINRA) and it seems that the shorts are trying hard to manipulate the market! The short borrow fee is 12.87% and the shorts have increased their position by another 600'000 shares to 6.14 million shares that are currently shorted. It should
CVM
SkeBallLarry SkeBallLarry 17 minutos hace
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
SkeBallLarry SkeBallLarry 18 minutos hace
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
cowtown jay cowtown jay 18 minutos hace
Here's a partial transcript of a discussion between Dr. John Campbell and Dr. Angus Dalgleish regarding a drug similar to lenz.

"21:17
we've done the phase one phase two is does it work every single phase two study we've done it clearly is of
21:23
benefit phase t
SkeBallLarry SkeBallLarry 20 minutos hace
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
Nrdc92 Nrdc92 36 minutos hace
Written like someone who doesn't have a clue, Jeunke. Beyond the rampant speculation in your post, it is ludicrous to believe that LWLG is in Tier 1 negotiations. No company during critical, major negotiations jettisons a respected  scientist and the company's CEO without a meaningful public explana
LWLG
Alexulf Alexulf 45 minutos hace
Steve Reinharz: A Visionary Leader in AI and Security Innovation


Steve Reinharz, the CEO and CTO of Artificial Intelligence Technology Solutions (AITX), is a true visionary in the field of AI and security innovation. His passion for developing AI-powered, autonomous security s
AITX
Iggy_Bot Iggy_Bot 53 minutos hace
If i can answer for Kash, the answer would be Nothing as usual. feckless
FireMechanic FireMechanic 54 minutos hace
Tne dow isn't 43,000 and Bitcoin isn't 100K!!! The current administration is working with the right people to keep these numbers. Unfortunately they will drop this in trump administration lap and say it's his fault. Gonna be millions of people in the world hurting soon mostly because of our crooked
BTCUSD
theswordman theswordman 57 minutos hace
💯
CKPT
janetcanada janetcanada 58 minutos hace
***I have been reading this in the past???....

1️⃣ 5 cents. Nickel.
2️⃣10 cents. Dime.
3️⃣ 25 cents Quarter.
4️⃣1 dollar.
RDAR
theswordman theswordman 59 minutos hace
The official answer is at clinical trials . gov.

Trial NCT06699836

It is a PH II with est start FEB 2025

est finish JUN 2028

60 patients. Last update 21 NOV 2024

This is an open label, randomized, two arm, multi-center study
MSS
123tom 123tom 1 hora hace
Looking at the chart, I'm thinking first the 10 to 9 area, in the next wave down. It would look discouraging to see a great rally from 8.50 to 14.50 fall all the way back down... that wouldn't feel like how a good news rally should be. I'd be ok to watch it hold at 10-11 and begin the next surge
AVXL
NocRob NocRob 1 hora hace
Those options are all for Berman at $0.21 with a sweetener around an acquisition. Both that strategy and Berman in general have proven to be complete busts. But if this somehow pushes past $0.21, I’m out and never looking back.
BLPG
wallstreet1231 wallstreet1231 1 hora hace
There has been nothing to cheer about.

Zero sales last two reporting period.

Filings still delinquent - what, over a year now.

A manufacturing facility-where?Me no see.

Oh, and a manufacturing facility - where?

And now chee
SNPW
demonsmith demonsmith 1 hora hace
Should I sale to you at 0.02
HLLK
LEFTY1182 LEFTY1182 1 hora hace
Where did he say that at?
RSPI
Plato_ Plato_ 1 hora hace
You're right MasterBlastr. Some here, with very large positions, have already announced that when the price hits 0.016 they will be "dumping stock on the market."
Between middle of July and end of September, I picked up millions and millions of millions of shares, at some point I recall a tr
GDVM
imbellish imbellish 2 horas hace
“Yeah I’m short from 45 cents still and it’s don’t know how the dollar works please protect me government”
FNMA
Elroy Jetson Elroy Jetson 2 horas hace
Mr T says he has "special talent" H1-B workers employed at his hotel properties, so H1-B visa workers are terrific - it's farm workers, builders and restaurant workers we need to deport, just like the UK did with Brexit.

Looking forward to food shortages and much higher prices at our

Su Consulta Reciente

EU
VIRP
Virbac
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados